Journal of Neural Transmission

Article	Citations
Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders?	86
Alterations in metabolites in the anterior cingulate cortex and thalamus and their associations with pain and empathy in patients with chronic mild pain: a preliminary study	82
Facets of movement disorders– a tribute to Heinz Reichmann	69
Proteinopathies: molecular mechanisms and diagnostic perspectives	62
Stress enhances heartbeat-evoked potentials, independent of continuous or intermittent theta burst stimulation of the interoceptive brain network targeting the right supramarginal gyrus: a preliminary	59
Eye movement study in essential tremor patients and its clinical correlates	55
Current perspectives on brain circuits involved in food addiction-like behaviors	54
A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response:	51
Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes	48
A wearable device-enabled therapeutic approach to improve joint attention in autism spectrum disorder: a prospective pilot study	48
Sitagliptin attenuates L-dopa-induced dyskinesia by regulating mitochondrial proteins and neuronal activity in a 6-OHDA-induced mouse model of Parkinson’s disease	48
Contrasting features between Tourette syndrome and secondary tic disorders	42
Cholinergic neurotransmission in the brain of streptozotocin-induced rat model of sporadic Alzheimer’s disease: long-term follow up	41
Pathogenesis of Parkinson’s disease: from hints from monogenic familial PD to biomarkers	40
Distinct gait dimensions are modulated by physical activity in Parkinson's disease patients	39
Far from being the end of the road: taking a closer look at neuropalliative care in Parkinson’s disease	38
Dopamine agonists in the treatment of Parkinson's disease: the show must go on	37
Non motor Parkinson: subtypes, biomarkers, stepped care and a journal!	36
Bradykinesia and rigidity modulated by functional connectivity between the primary motor cortex and globus pallidus in Parkinson’s disease	35
Kindness in science does matter	35
Reduced vagal activity in borderline personality disorder is unaffected by intranasal oxytocin administration, but predicted by the interaction between childhood trauma and attachment insecurity	35
Camillo Golgi’s contributions to the anatomic basis of sensitivity in tendons	34
Association between autonomic dysfunction with motor and non-motor symptoms in patients with Parkinson's disease	32
The pathobiology of depression in Huntington’s disease: an unresolved puzzle	29
Comparison of inflammatory biomarker levels in neurodegenerative proteinopathies: a case-control study	28

Botulinum toxin and conservative treatment strategies in people with cervical dystonia: an online survey	28
The role of immune and inflammatory-related indicators in cognitive dysfunction and disease severity in patients with parkinson’s disease	28
Unusual delayed and prolonged arm weakness and atrophy following botulinum toxin injection for musician’s cramp: case report	28
Unravelling head tremor mechanisms: insights from speech analysis in essential tremor and cervical dystonia	26
Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016	26
The spectrum of behavioral disorders in amyotrophic lateral sclerosis: current view	26
Site-activated multi target iron chelators with acetylcholinesterase (AChE) and monoamine oxidase (MAO) inhibitory activities for Alzheimer’s disease therapy	25
Botulinum toxin effects on biochemical biomarkers related to inflammation-associated head and neck chronic conditions: a systematic review of clinical research	24
Constipation and pain in Parkinson’s disease: a clinical analysis	24
Old problems, new solutions: harnessing technology and innovation in Parkinson’s disease—evidence and experiences from Thailand	23
Inhaled levodopa for threatening impending OFF episodes in managing Parkinson’s disease	22
The corticospinal tract in multiple sclerosis: correlation between cortical excitability and magnetic resonance imaging measures	21
Illness perceptions in pre-operative Parkinson’s disease patients	21
Regulation of circadian gene activity in fibroblasts from ADHD patients through Rosiglitazone: a pilot study	21
Impact of APOE and MAPT genetic profile on the cognitive functions among Amyotrophic Lateral Sclerosis Tunisian patients	21
The relationship of early life adversity and physiological synchrony within the therapeutic triad in horse-assisted therapy	20
MeDeMSA care study protocol: developing personalized best medical care with integrated mobile palliative and telemedicine support for individuals with multiple system atrophy	20
Insulin resistance: fueling oxidative stress and neurodegeneration	20
Chronic exposure to a synthetic cannabinoid alters cerebral brain metabolism and causes long-lasting behavioral deficits in adult mice	19
A call to action: revitalizing the German parkinson’s research ecosystem post-pandemic	18
Axial postural abnormalities and pain in Parkinson’s disease	18
Sleep disorders among frontline nurses after the COVID-19 outbreak: a large-scale cross-sectional study	17
Potentially inappropriate medications according to PRISCUS list and FORTA (Fit fOR The Aged) classification in geriatric psychiatry: a cross-sectional study	17
Drug repurposing and new drug targets: perspectives for novel treatment options in mental health disorders	17
Proteinopathies associated to repeat expansion disorders	17
The brainstem reticular formation pivots abnormal neural transmission in the course of Anorexia Nervosa	17
Prenatal exposure to morphine enhances excitability in locus coeruleus neurons	17
The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone	16
Effects of association between resveratrol and ketamine on behavioral and biochemical analysis in mice	16
Neuroscience and addiction research: current advances and perspectives	16
Serum glial fibrillary acidic protein is elevated in early-stage late-onset essential tremor and associated with tremor progression	16
MAOA methylation is associated with impulsive and antisocial behaviour: dependence on allelic variation, family environment and diet	16
In situ stoichiometry amounts of p62 and poly-ubiquitin exceed the increase of alpha-synuclein during degeneration of catecholamine cells induced by autophagy inhibition in vitro	16
Advanced therapy in advanced Parkinson’s disease: money’s too tight to mention	16
Small intestinal bacterial overgrowth in Alzheimer’s disease	15
Language in autism: domains, profiles and co-occurring conditions	14
Type A monoamine oxidase; its unique role in mood, behavior and neurodegeneration	14
Atrophy of cerebellar lobule VI and primary motor cortex in cervical dystonia - a region of interest-based study	14
Psychological, neuroendocrine and inflammatory stress responses in women after miscarriage or stillbirth: investigating early psychobiological adaptations to potential traumatic events	14
The two-network framework of number processing: a step towards a better understanding of the neural origins of developmental dyscalculia	14
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease	14
Autism Spectrum Disorder and auditory sensory alterations: a systematic review on the integrity of cognitive and neuronal functions related to auditory processing	14
Exploring developmental trajectories throughout adolescence of children with autism spectrum disorder without intellectual disability	13
Characteristics of behavioural addiction in Parkinson’s disease patients with self-reported impulse control disorder and controls matched for levodopa equivalent dose: a matched case–control study	13
A historical review of multiple system atrophy with a critical appraisal of cellular and animal models	13
The natural course of idiopathic cervical dystonia	13
Increased hair cortisol in mothers of children with ADHD symptoms and psychosocial adversity background	13
The vicious circle between homocysteine, methyl group-donating vitamins and chronic levodopa intake in Parkinson’s disease	13
Superoxide dismutase isozymes in cerebral organoids from autism spectrum disorder patients	13
Issues for patchy tissues: defining roles for gut-associated lymphoid tissue in neurodevelopment and disease	13

The impact of cerebral vasomotor reactivity on cerebrovascular diseases and cognitive impairment	12
From the tyrosine hydroxylase hypothesis of Parkinson’s disease to modern strategies: a short historical overview	12
Perceived social support declines after deep brain stimulation surgery in patients with Parkinson’s disease	12
Exploring transferability in psychiatric interventions: a conceptual framework	12
Tips and tricks in tremor treatment	12
Sexual dysfunction in men with young onset Parkinson's disease	12
Sex differences in schizophrenia: a longitudinal methylome analysis	12
Cognitive impairment in Parkinson’s disease and other parkinsonian syndromes	12
Investigation of the nonmotor symptoms in patients with STN-DBS therapy in comparison with those without STN-DBS	11
Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide	11
Patterns of striatal dopamine depletion and motor deficits in de novo Parkinson’s disease	11
Writing tremor in Parkinson’s disease: frequency and associated clinical features	11
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease	11
Unveiling the link between chronic pain and misuse of opioids and cannabis	11
Maternal separation and its developmental consequences on anxiety and parvalbumin interneurons in the amygdala	11
Protein clearance strategies for disease intervention	11
Transcriptional dysregulation in the cerebellum triggered by oligodendroglial α-synucleinopathy: insights from a transgenic mouse into the early disease mechanisms of MSA	11
Oligodendrocytes matter: a review of animal studies on early adversity	11
High-dose glucocorticoids in COVID-19 patients with acute encephalopathy: clinical and imaging findings in a retrospective cohort study	10
Therapeutic use of medical Cannabis in neurological diseases: a clinical update	10
Neuromarkers in addiction: definitions, development strategies, and recent advances	10
Real-world experience with continuous subcutaneous foslevodopa/foscarbidopa infusion: insights and recommendations	10
RNA sequencing of the thalamus and rostral ventral medulla in rats with chronic orofacial pain	10
Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels	10
Usability of the digit-tracking technique in a geriatric population of inpatients with and without neurocognitive disorders: The DIGICOG-start study	10
Kurt Jellinger, Doyen of international neuropathology	10
A sporadic Parkinson’s disease model via silencing of the ubiquitin–proteasome/E3 ligase component, SKP1A	10
Botulinum toxin treatment for hemifacial spasm: harmonising neurological and aesthetic outcomes	10
Clinimetrics of the Italian version of the Montreal Cognitive Assessment (MoCA) in adult-onset idiopathic focal dystonia	10
If you can't be with the one you love, love the one you're with (C, S, N & Y)	10
The association of the 5-HTTLPR polymorphism and the response to different stressors in healthy males	10
Plasma prolactin and symptoms of schizophrenia	10
Depression and anxiety in multiple sclerosis. Review of a fatal combination	9
Treatment; Moussa B.H. Youdim	9
Correlation between the MNCD classification-based staging of Parkinson’s disease and quality of life: a cross-sectional study	9
Environmental opportunities facilitating cognitive development in preschoolers: development of a multicriteria index	9
Mild cognitive impairment in amyotrophic lateral sclerosis: current view	9
Correction: The neural structures of theory of mind are valence-sensitive: evidence from three tDCS studies	9
Differential diagnosis of Huntington’s disease− neurological aspects of NKX2-1-related disorders	9
A smartphone-based tapping task as a marker of medication response in Parkinson’s disease: a proof of concept study	9
Depression in dementia with Lewy bodies: a critical update	9
Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice	9
Changes in RNA expression levels during antidepressant treatment: a systematic review	9
MEF2C gene variations are associated with ADHD in the Chinese Han population: a case–control study	9
Motor and non-motor improvements following short-term multidisciplinary day-clinic care in Parkinson´s disease	8
Polymorphisms of COMT and CREB1 are associated with treatment-resistant depression in a Chinese Han population	8
Mild cognitive impairment in Huntington’s disease: challenges and outlooks	8
The heterogeneity of Parkinson’s disease	8
The sex-specific relationship of ghrelin and cognition in Chinese han first-episode drug-naive major depressive disorder	8
Facial emotion recognition deficits are associated with hypomimia and related brain correlates in Parkinson’s disease	8
Optimised endoscopic access for intrajejunal levodopa application in idiopathic Parkinson's syndrome	8
The efficacy of acoustic-based articulatory phenotyping for characterizing and classifying four divergent neurodegenerative diseases using sequential motion rates	8
Catecholamines and Parkinson’s disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview	8
Psychotherapies in opioid use disorder: toward a step-care model	8
Advanced is advanced is advanced is advanced	8
The relationship between serum prolactin levels and cognitive function in drug-naïve schizophrenia patients: a cross-sectional study	8
Locus Coeruleus magnetic resonance imaging: a comparison between native-space and template-space approach	8
Parkinson´s day-clinic: which patients should be selected and what services should be offered for successful therapy?	8
Cognition and Activity of Daily Living Function in people with Parkinson’s disease	8
From parents to children: associations of traffic risks with impulsivity, family relationships and serotonin transporter genotype	8
Pharmacological considerations for treating neuroinflammation with curcumin in Alzheimer’s disease	8
The pathobiological basis of depression in Parkinson disease: challenges and outlooks	8
The akinetic crisis in Parkinson´s disease- the upper end of a spectrum of subacute akinetic states	8
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t	8
Mild cognitive impairment in multiple system atrophy: a brain network disorder	8
Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone	8
Iron and copper ions accelerate and modify dopamine oxidation to eumelanin: implications for neuromelanin genesis	8
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease	7
GBA-associated PD: chances and obstacles for targeted treatment strategies	7
Correction to: Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy	7
Botulinum toxin therapy: past, present and future developments	7
Driving innovation in addiction treatment: role of transcranial magnetic stimulation	7
Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson’s disease	7
Bioinformatics approach reveals the critical role of the NOD-like receptor signaling pathway in COVID-19-associated multiple sclerosis syndrome	7
The impact of short-term blood pressure variability on cognitive decline in Parkinson’s disease patients without co-morbidities	7
Association between alcohol consumption and mortality in Parkinson’s disease	7
Probing the properties of PTEN specific botulinum toxin type E mutants	7
Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review	7
Interrater reliability of motor severity scales for hemifacial spasm	7
Concomitant pathologies and their impact on Huntington’s disease. A brief review of current evidence	7

Drug interactions in a sample of inpatients diagnosed with cannabis use disorder	7
Association of polygenic risk scores, traumatic life events and coping strategies with war-related PTSD diagnosis and symptom severity in the South Eastern Europe (SEE)-PTSD cohort	7
Genetic and environmental mouse models of autism reproduce the spectrum of the disease	7
A structured framework for emotion-cognition dynamics: Implications for assessment and intervention	7
Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network	7
Deep brain stimulation in progressive supranuclear palsy: a dead-end story? A narrative review	7
Internet-based cognitive behavioral therapy in children and adolescents with obsessive compulsive disorder: a feasibility study	7
Repurposing drugs against Alzheimer’s disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?	7
Nicotinic regulation of microglia: potential contributions to addiction	7
Neurogenic orthostatic hypotension in Parkinson’s disease: is there a role for locus coeruleus magnetic resonance imaging?	7
Tools and criteria to select patients with advanced Parkinson’s disease for device-aided therapies: a narrative review	7
Plasma concentrations of anti-inflammatory cytokine TGF-β are associated with hippocampal structure related to explicit memory performance in older adults	7